Fresenius Health Partners, the value-based care division of Fresenius Medical Care North America; InterWell Health; and Cricket Health announced plans to merge to create a new company to provide consumer-centered, value-based kidney care focused on mid- and late-stage chronic kidney disease. The goal of the merger is to reduce hospital admissions, slow disease progression, and increase transplant rates and home dialysis. The new company is valued at $2.4 billion and will operate under the InterWell Health brand. The transaction is anticipated to close in the second half of 2022. InterWell Health will provide its network . . .
News Report |